|
|
|
Session 7: Master Medicinal Chemistry to Develop More Potent, Safe and New Anti-Major Disease Medicines |
|
Title: PH-Gradient HPLC as a New Method of Simultaneous High-Throughput Determination of pKa and Lipophilicity of Drug Candidates
Dr. Roman Kaliszan, Professor, orresponding Member of the Polish Academy of Sciences, Rector of the Medical University of Gdansk, Poland
|
|
Title: Human MAP3 Kinase COT ¨C Characterization and Assay Development/ Applications in Small Molecule Drug Discovery
Dr. Yong Jia, Abbott Bioresearch Center, USA
|
|
Title: Glucokinase Activators
Dr. Ramakanth Sarabu, Hoffmann-La Roche, USA
|
|
Title: Targeting Major Cancer, Infectious and Metabolic Diseases
Dr. Jiancun Zhang, Guangzhou Institute of Biomedicine and Health Chinese Academy of Sciences, China
|
| |
Title: Asymmetric Synthesis of Quaternary Amino Acid Derivatives by Kinetic Resolution of Azlactones Using Copper Catalyzed Alcoholysis Reactions
Dr. Makoto TOKUNAGA, Associate Professor, Hokkaido University, Catalysis Research Center, Japan
|
| |
Title: The study on selective hydrolysis of steroid saponin
Dr. Bing Feng, the Academy of Military Medical Sciences, China
|
|
Title: Octahydroindoles as MCH1 Receptor Antagonists for the Potential Treatment of Obesity
Dr. Martin Scobie, Biovitrum AB, Uppsala, Sweden
|
|
Title: Recent Developments in the Use of Mylabris and Analogues Derived There from As Potential Anti-cancer Agents
Dr. Adam McCluskey, Professor, Chemistry, The University of Newcastle, Callaghan, Australia |
|
Title: Innovation for Pharmaceuticals: the role of catalysis for better industrial processes and of clever formulations for controlled releases
Dr. Piccolo Oreste, Studio Consulenza Scientifica, Italy
|
|
Title: Structure Based Drug Design and Lead Optimization When¡¡There is No Receptor Crystal Structure
Dr. Nanda Ghoshal, Drug Design, Development and Molecular Modelling Division, Indian Institute of Chemical Biology, Kolkata, India |
| |
Title: Novel Optimized Drug Candidates by Parallel Multi-Property Drug Design
Dr. Jay Jie-Qiang Wu, President and CEO of VM Discovery, Inc., USA
|
|
|
Home
